Connection
Scott Sagel to Anti-Inflammatory Agents
This is a "connection" page, showing publications Scott Sagel has written about Anti-Inflammatory Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.146 |
|
|
|
-
Jain R, Baines A, Khan U, Wagner BD, Sagel SD. Evaluation of airway and circulating inflammatory biomarkers for cystic fibrosis drug development. J Cyst Fibros. 2021 01; 20(1):50-56.
Score: 0.552
-
Sagel SD. The challenges of developing effective anti-inflammatory agents in cystic fibrosis. J Cyst Fibros. 2015 Mar; 14(2):164-6.
Score: 0.378
-
Sagel SD. Identifying novel endpoints for cystic fibrosis clinical trials. Adv Pediatr. 2005; 52:115-27.
Score: 0.189
-
Martiniano SL, Wagner BD, Levin A, Nick JA, Sagel SD, Daley CL. Safety and Effectiveness of Clofazimine for Primary and Refractory Nontuberculous Mycobacterial Infection. Chest. 2017 10; 152(4):800-809.
Score: 0.028